EA200301062A1 - Фармацевтические комбинации на основе производных пиридоиндолона и противораковых агентов - Google Patents

Фармацевтические комбинации на основе производных пиридоиндолона и противораковых агентов

Info

Publication number
EA200301062A1
EA200301062A1 EA200301062A EA200301062A EA200301062A1 EA 200301062 A1 EA200301062 A1 EA 200301062A1 EA 200301062 A EA200301062 A EA 200301062A EA 200301062 A EA200301062 A EA 200301062A EA 200301062 A1 EA200301062 A1 EA 200301062A1
Authority
EA
Eurasian Patent Office
Prior art keywords
peridodinodolon
derivatives
basis
pharmaceutical combinations
tract agents
Prior art date
Application number
EA200301062A
Other languages
English (en)
Other versions
EA005930B1 (ru
Inventor
Бернар Буррье
Пьер Казелла
Жан-Мари Дерок
Original Assignee
Санофи-Синтелябо
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи-Синтелябо filed Critical Санофи-Синтелябо
Publication of EA200301062A1 publication Critical patent/EA200301062A1/ru
Publication of EA005930B1 publication Critical patent/EA005930B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение относится к комбинации соединений формулы (I) с различными противораковыми агентами.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200301062A 2001-04-27 2002-04-26 Фармацевтические комбинации на основе производных пиридоиндолона и противораковых агентов EA005930B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0105843A FR2823975B1 (fr) 2001-04-27 2001-04-27 Nouvelle utilisation de pyridoindolone
PCT/FR2002/001450 WO2002087575A1 (fr) 2001-04-27 2002-04-26 Associations pharmaceutiques a base de derives de pyridoindolone et d'agents anticancereux

Publications (2)

Publication Number Publication Date
EA200301062A1 true EA200301062A1 (ru) 2004-04-29
EA005930B1 EA005930B1 (ru) 2005-08-25

Family

ID=8862882

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200301062A EA005930B1 (ru) 2001-04-27 2002-04-26 Фармацевтические комбинации на основе производных пиридоиндолона и противораковых агентов

Country Status (33)

Country Link
US (3) US7524857B2 (ru)
EP (2) EP1385513B1 (ru)
JP (2) JP2004531538A (ru)
KR (1) KR100847413B1 (ru)
CN (2) CN1505511A (ru)
AR (1) AR034313A1 (ru)
AT (2) ATE338548T1 (ru)
BG (2) BG108260A (ru)
BR (1) BR0209138A (ru)
CA (2) CA2443012C (ru)
CY (1) CY1105813T1 (ru)
CZ (2) CZ295224B6 (ru)
DE (2) DE60214533T2 (ru)
DK (2) DK1385512T3 (ru)
EA (1) EA005930B1 (ru)
EE (2) EE200300465A (ru)
ES (2) ES2271264T3 (ru)
FR (1) FR2823975B1 (ru)
HU (2) HUP0400745A2 (ru)
IL (4) IL158312A0 (ru)
IS (1) IS2441B (ru)
MX (1) MXPA03009639A (ru)
NO (2) NO20034785L (ru)
NZ (1) NZ528671A (ru)
PL (2) PL366910A1 (ru)
PT (2) PT1385513E (ru)
RS (2) RS50791B (ru)
RU (1) RU2292888C9 (ru)
SK (2) SK13252003A3 (ru)
TW (1) TWI252104B (ru)
UA (1) UA74876C2 (ru)
WO (2) WO2002087575A1 (ru)
ZA (1) ZA200307785B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823975B1 (fr) * 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
US7456193B2 (en) * 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2846329B1 (fr) * 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
FR2869316B1 (fr) * 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268772A (en) * 1968-03-15 1972-03-29 Glaxo Lab Ltd NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US4263304A (en) * 1978-06-05 1981-04-21 Sumitomo Chemical Company, Limited 7 H-indolo[2,3-c]isoquinolines
SU833971A1 (ru) * 1979-07-10 1981-05-30 Ленинградский Химико-Фармацевтическийинститут Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ
SU833972A1 (ru) 1979-10-26 1981-05-30 Институт Физико-Органической Химиии Углехимии Ah Украинской Ccp Имидазо(4,5-с)пиридиний иодиды вКАчЕСТВЕ пРОМЕжуТОчНыХ пРОдуКТОВ дл СиНТЕзА фуНгицидОВ
FR2595701B1 (fr) * 1986-03-17 1988-07-01 Sanofi Sa Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant
US5035252A (en) * 1990-12-14 1991-07-30 Mondre Steven J Nicotine-containing dental floss
EP0581388A1 (en) * 1992-07-30 1994-02-02 Glaxo Group Limited Pyridoindolone Methansulphonate as 5HT and 5HT3 receptor antagonists
JPH10501686A (ja) * 1994-04-13 1998-02-17 ザ ロックフェラー ユニヴァーシティ 神経系の細胞へのｄｎａのａａｖ仲介送達
DE19502753A1 (de) * 1995-01-23 1996-07-25 Schering Ag Neue 9H-Pyrido[3,4-b]indol-Derivate
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
DE19624659A1 (de) * 1996-06-20 1998-01-08 Klinge Co Chem Pharm Fab Neue Pyridylalken- und Pyridylalkinsäureamide
FR2765581B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
FR2765582B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
EP1068205A1 (en) * 1998-04-02 2001-01-17 Neurogen Corporation Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino 2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino 4,5-b]indole derivatives: crf1 specific ligands
IT1313592B1 (it) 1999-08-03 2002-09-09 Novuspharma Spa Derivati di 1h-pirido 3,4-b indol-1-one.
US20020156016A1 (en) * 2001-03-30 2002-10-24 Gerald Minuk Control of cell growth by altering cell membrane potentials
FR2823975B1 (fr) * 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846330B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
FR2846329B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
US6958347B2 (en) 2002-12-18 2005-10-25 Pfizer Inc. Aminophenanthridinone and aminophenanthridine as NPY-5 antagonists
FR2869316B1 (fr) 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
JP2004528343A (ja) 2004-09-16
PT1385513E (pt) 2007-01-31
NO20034787D0 (no) 2003-10-24
ES2254683T3 (es) 2006-06-16
NZ528671A (en) 2004-06-25
SK13242003A3 (sk) 2004-03-02
PL366910A1 (en) 2005-02-07
DE60214533T2 (de) 2007-06-21
US20040122036A1 (en) 2004-06-24
KR100847413B1 (ko) 2008-07-18
DE60214533D1 (de) 2006-10-19
RS50791B (sr) 2010-08-31
BR0209138A (pt) 2004-06-08
DE60208365T2 (de) 2006-09-07
CN1240382C (zh) 2006-02-08
CY1105813T1 (el) 2011-02-02
TWI252104B (en) 2006-04-01
WO2002087574A2 (fr) 2002-11-07
KR20040015138A (ko) 2004-02-18
PL366916A1 (en) 2005-02-07
ES2271264T3 (es) 2007-04-16
EP1385513B1 (fr) 2006-09-06
US7524857B2 (en) 2009-04-28
WO2002087575A1 (fr) 2002-11-07
IS6984A (is) 2003-10-09
RS50790B (sr) 2010-08-31
DE60208365D1 (de) 2006-02-02
IL158266A0 (en) 2004-05-12
DK1385513T3 (da) 2007-01-15
WO2002087574A3 (fr) 2003-02-13
US20050272760A1 (en) 2005-12-08
ATE314070T1 (de) 2006-01-15
SK13252003A3 (sk) 2004-03-02
MXPA03009639A (es) 2004-06-30
AR034313A1 (es) 2004-02-18
CZ299465B6 (cs) 2008-08-06
NO20034785L (no) 2003-12-23
RU2292888C9 (ru) 2007-06-20
CA2443012A1 (en) 2002-11-07
CN1505510A (zh) 2004-06-16
HUP0400744A2 (hu) 2004-06-28
CZ20032910A3 (en) 2004-07-14
HK1059895A1 (en) 2004-07-23
CZ20032909A3 (en) 2004-06-16
EA005930B1 (ru) 2005-08-25
CN1505511A (zh) 2004-06-16
ATE338548T1 (de) 2006-09-15
BG108261A (bg) 2004-12-30
CA2444334A1 (fr) 2002-11-07
DK1385512T3 (da) 2006-05-22
IL158312A0 (en) 2004-05-12
CA2443012C (fr) 2009-07-28
US7160895B2 (en) 2007-01-09
PT1385512E (pt) 2006-05-31
US6967203B2 (en) 2005-11-22
IL158266A (en) 2009-09-01
HK1060066A1 (en) 2004-07-30
EE200300466A (et) 2003-12-15
RU2003130376A (ru) 2005-04-10
NO20034787L (no) 2003-12-23
IL158312A (en) 2009-09-01
UA74876C2 (en) 2006-02-15
US20040122027A1 (en) 2004-06-24
YU83403A (sh) 2006-08-17
EP1385512A2 (fr) 2004-02-04
FR2823975B1 (fr) 2003-05-30
EP1385512B1 (fr) 2005-12-28
BG108260A (bg) 2004-12-30
EP1385513A1 (fr) 2004-02-04
EE200300465A (et) 2003-12-15
ZA200307785B (en) 2004-10-06
RU2292888C2 (ru) 2007-02-10
HUP0400745A2 (hu) 2004-08-30
JP2004531538A (ja) 2004-10-14
YU83903A (sh) 2006-08-17
IS2441B (is) 2008-11-15
FR2823975A1 (fr) 2002-10-31
NO20034785D0 (no) 2003-10-24
CZ295224B6 (cs) 2005-06-15

Similar Documents

Publication Publication Date Title
EA200300829A1 (ru) Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6
EA200601007A1 (ru) 7-фенилалкилзамещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза)полимеразы
EA200400006A1 (ru) Бензоилсульфонамиды и сульфонилбензамидины для применения в качестве противоопухолевых агентов
DK1413582T3 (da) Dimere pyrrolobenzodiazepiner
EA200300919A1 (ru) N-замещенные неарильные гетероциклические антагонисты nmda/nr2b
EA200700188A1 (ru) Производные замещенного 2-алкилхиназолинона как ингибиторы parp
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
NL300877I2 (nl) obeticholzuur
EA200201179A1 (ru) Производные 2-аминокарбонил-9h-пурина
EA200500146A1 (ru) Моноэтансульфонат 3-z-[1-4-(n-((4-метилпиперазин-1-ил)метилкарбонил)-n-метиламино)анилино)-1-фенилметилен]-6-метоксикарбонил-2-индолинона и его применение в составе фармацевтической композиции
EA200300050A1 (ru) Гликопептидфосфонатные производные
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
EA200301142A1 (ru) Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6
DE60230890D1 (de) Indolizine als kinaseproteinhemmer
EA200601002A1 (ru) 6-алкенил и 6-фенилалкил замещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза) полимеразы
EA200100757A1 (ru) Хинолинкарбоксамиды в качестве противовирусных агентов
EA200700185A1 (ru) Производные хиназолиндиона в качестве ингибиторов parp
EA200300836A1 (ru) Производные фталазинон-пиперидина в качестве ингибиторов pde4
EA200301100A1 (ru) Новые фталазиноны
SE9901077D0 (sv) Novel use
EA200501341A1 (ru) Противобактериальные индолоноксазолидиноны, промежуточные соединения для их получения и содержащие их фармацевтические композиции
SE9801494D0 (sv) Novel use
EA200100852A1 (ru) Производные резорцина
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
CY1111432T1 (el) Τετραϋδροκινολινες για χρηση ως διαμορφωτες της μιτοτικης κινητικης πρωτεϊνης eg5

Legal Events

Date Code Title Description
HC1A Change in name of an applicant in a eurasian application
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU